Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
On August 28, 2018, Illinois Governor Bruce Rauner signed into law SB336, the Alternatives to Opioids Act of 2018.
By Brian Allen, VP of Government Affairs
The Vermont Department of Labor has proposed a rule that would, by reference, incorporate the Department of Health opioid prescribing guidelines fo
Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.
From the moment an injury occurs, to the day an injured worker returns to work, the journey a workers’ compensation claim may take is complex, invo
Orlando, FL (WorkersCompensation.com) - “Diversity and Inclusion – Objective Examples of Meaningful Inclusion†panel member Chikita Man